Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Citigroup Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $231.0B | |
|---|---|---|
| Revenue (ttm) | 83.3B | |
| Net income (ttm) | 17.9B | |
| EPS (ttm) | $10.2 | |
| Shares out | 1.7B | |
| P/E (trailing) | 12.2x | |
| P/E (forward) | 10.6x | |
| Dividend | $2.68 (2.16%) | |
| Volume | 4,504,854 | |
| Beta | 1.11 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $71.88B | $75.34B | $78.07B | $80.72B | $85.23B | +4.3% |
| Gross profit | $75.78B | $69.37B | $67.90B | $71.12B | $75.05B | -0.2% |
| Operating income | $27.47B | $18.81B | $12.91B | $17.05B | $19.83B | -7.8% |
| Net income | $21.95B | $14.85B | $9.23B | $12.68B | $14.31B | -10.2% |
| EPS (diluted) | $10.14 | $7.00 | $4.04 | $5.94 | $6.99 | -8.9% |
| EBITDA | $31.43B | $23.07B | $17.47B | $21.36B | $24.20B | -6.3% |
| R&D | — | — | — | — | $2.33B | — |
| SG&A | $25.25B | $26.75B | $29.32B | $28.63B | $29.73B | +4.2% |
Recent company headlines from major financial publishers.
The base path accepts the estimate-backed recovery but does not extend it indefinitely. It would weaken if post-FY2027 profitability fails to normalize or regional concentration rises materially.
Upside persists only if post-FY2027 earnings growth proves durable and the observed regional revenue breadth translates into steadier profit. Rising diluted shares or renewed margin weakness would disconfirm this path.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.2% | $103 | $104 | $105 | $106 | $108 |
| 8.2% | $92.2 | $92.2 | $92.2 | $92.1 | $92.0 |
| 9.2% | $83.9 | $83.5 | $82.9 | $82.2 | $81.4 |
| 10.2% | $77.3 | $76.5 | $75.7 | $74.7 | $73.6 |
| 11.2% | $71.7 | $70.8 | $69.9 | $68.8 | $67.5 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
